GSE117633
RNA-binding protein A1CF modulates plasma triglyceride levels  through posttranscriptional regulation of stress-induced VLDL secretion
A recent human exome-chip study on plasma lipids identified a missense mutation in the 3 A1CF (APOBEC1 complementation factor) gene that associates with elevated TG levels, but how A1CF, 4 an RNA binding protein, influences plasma TG is unknown. Overall design: RNA-binding protein A1CF modulates plasma triglyceride levels  through posttranscriptional regulation of stress-induced VLDL secretion